209 related articles for article (PubMed ID: 7019377)
21. Effect of a monoclonal anti-lyt-1.1 on the functional activity of precursor, effector, and regulatory cells specific for murine alloantigens.
Shaw J; Pilarski LM; Al Adra AR; Leigh JB; Wilkins J; Hogarth PM; McKenzie IF; Paetkau V
Transplantation; 1981 Jan; 31(1):56-60. PubMed ID: 6165110
[TBL] [Abstract][Full Text] [Related]
22. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
23. Effector cells in allelic H-2 class I-incompatible skin graft rejection.
Ichikawa T; Nakayama E; Uenaka A; Monden M; Mori T
J Exp Med; 1987 Oct; 166(4):982-90. PubMed ID: 3309129
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
25. Which T cells cause graft rejection?
Loveland BE; McKenzie IF
Transplantation; 1982 Mar; 33(3):217-21. PubMed ID: 6801833
[No Abstract] [Full Text] [Related]
26. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
Eichmann K; Jönsson JI; Falk I; Emmrich F
Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
[TBL] [Abstract][Full Text] [Related]
27. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
Mayumi H; Good RA
J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
[TBL] [Abstract][Full Text] [Related]
28. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
[TBL] [Abstract][Full Text] [Related]
29. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
30. Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.
Azuma T; Sato S; Kitagawa S; Hori S; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Jul; 143(1):1-8. PubMed ID: 2525143
[TBL] [Abstract][Full Text] [Related]
31. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
Nanishi F; Nomoto K; Taniguchi K; Kubo C
Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
[TBL] [Abstract][Full Text] [Related]
33. The role of epidermal cells in the induction of delayed-type hypersensitivity to alloantigens.
Tamaki K; Furue M
J Invest Dermatol; 1985 Jul; 85(1):20-4. PubMed ID: 3891874
[TBL] [Abstract][Full Text] [Related]
34. Hypersensitivity reactions in the small intestine. VII. Induction of the intestinal phase of murine graft-versus-host-reaction by Lyt 2- T cells activated by I-A alloantigens.
Mowat AM; Borland A; Parrott DM
Transplantation; 1986 Feb; 41(2):192-8. PubMed ID: 3484848
[TBL] [Abstract][Full Text] [Related]
35. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
36. The effect of ultraviolet B irradiation on delayed-type hypersensitivity, cytotoxic T lymphocyte activity, and skin graft rejection.
Tamaki K; Iijima M
Transplantation; 1989 Feb; 47(2):372-6. PubMed ID: 2645721
[TBL] [Abstract][Full Text] [Related]
37. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
[TBL] [Abstract][Full Text] [Related]
38. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
39. Lysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers.
Barker E; Wise JA; Dray S; Mokyr MB
Cancer Res; 1989 Sep; 49(18):5007-15. PubMed ID: 2788494
[TBL] [Abstract][Full Text] [Related]
40. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
Barker E; Mokyr MB
Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
